Improving the in vivo QTc assay: Nonclinical concentration-QTc modeling for risk assessment
- PMID: 38777240
- DOI: 10.1016/j.vascn.2024.107515
Improving the in vivo QTc assay: Nonclinical concentration-QTc modeling for risk assessment
Keywords: Canine; Cardiovascular; Concentration-response modeling; ICH E14/S7B Q&As; In vivo; Moxifloxacin; Nonhuman primate; QTc prolongation; Safety pharmacology; Telemetry.
Conflict of interest statement
Declaration of competing interest None of the authors has any conflicts of interest, other than their employment in commercial biopharmaceutical companies or contract research organizations (CROs). No information is presented in this paper that advocates for or promotes commercial products from any of our organizations.
MeSH terms
LinkOut - more resources
Full Text Sources
Research Materials